Recent evidence identified multiple Henipavirus species in Africa distinct from those in Southeast Asia and Australia. The reported fusion glycoprotein (F) sequence of the African Gh-M74a strain (GhV-F) is likely incorrect: a single base pair deletion near the N terminus results in multiple aberrancies. Rectifying this by adding single nucleotide insertions results in a GhV-F that now possesses a signal peptide, is efficiently cell surface expressed, exhibits syncytium formation when coexpressed with GhV-G protein, and mediates pseudotyped viral particle entry.
O
ne recent global survey of ϳ5,000 bat specimens identified 66 new species of paramyxoviruses-more species than were present in the GenBank database prior to the publication (1) . This is worrisome, as paramyxoviruses are unusually susceptible to cross-species transfers, exhibiting one of the highest rates of host switching among RNA viruses (2) . In particular, Drexler et al. reported Ͼ20 distinct viral clades within the genus Henipavirus, with Nipah (NiV), Hendra (HeV), and Cedar (CedPV) viruses from Southeast Asia and Australia representing only three of those clades (1, 3) . Therefore, the phylogenetic diversity of henipaviruses (HNVs) is far greater than was previously thought. NiV and HeV cause lethal zoonoses in humans; infections can result in mortality rates exceeding 90% (4) (5) (6) .
HNVs also exhibit a broader species tropism than other paramyxoviruses, in part due to the highly conserved ephrin-B2
and -B3 receptors that these viruses use (7) . Although documented HNV spillover events are currently limited to Southeast Asia and Australia, the diversity of HNVs in endemic bat species (Eidolon helvum) throughout Africa (1, 8) raises the possibility of incipient spillover events. Indeed, a recent analysis of almost 500 human sera from Cameroon detected the significant presence of cross-neutralizing anti-NiV antibodies in groups considered to be at high risk for zoonotic exposure (e.g., bat bush meat butchers) (O. Pernet Schneider, N. Wolfe, B. Lee, presented at the Negative Strand Virus Meeting, Granada, Spain, 2013). The multiple clades of African HNVs were determined from sequence analysis of an L gene segment. However, the almost-full-length genomic sequence of one African HNV from Ghana (clone GH-M74a) was reported (GenBank accession number HQ660129.1); we term this virus GhV, and the fusion and attachment envelope glycoproteins of GhV are termed GhV-F= and GhV-G, respectively. GhV-F= and GhV-G share only 26 to 56% sequence identity with their NiV/HeV counterparts.
Functional properties of GhV envelope glycoproteins. To examine the biological properties associated with GhV-F= and GhV-G, we first codon optimized and expressed the GhV-F= and -G genes from their predicted GenBank reference sequences (AFH96010.1 and AFH96011.1, respectively). Consistent with recently published data (9), cell surface GhV-G bound to soluble ephrin-B2 (Fig. 1A) . Next, we examined the fusogenicity of GhV-F= and GhV-G on human U87 glioblastoma cells, which express the HNV receptors ephrin-B2 and -B3 (10) and are highly permissive to HNV envelope (F/G)-mediated entry and syncytium formation (11) . Curiously, while GhV-G cross-complemented NiV-F and HeV-F to form syncytia in permissive U87 cells (Fig. 1B) , GhV-F= exhibited little to no fusogenic activity when complemented with heterotypic NiV-G and HeV-G or even its homotypic GhV-G (Fig. 1B) . Neither GhV-F= (data not shown) nor GhV-G alone (see Fig. 5A ) induced any syncytium formation. Thus, while GhV-G was fully functional for receptor binding and could trigger heterotypic HNV-F proteins, GhV-F= appeared to be functionally compromised compared to NiV-F or HeV-F (Fig.  1C ). For clarity, we designate this original GhV-F sequence GhV-F=.
The N terminus of GhV-F= lacks a canonical signal peptide sequence. Sequence alignment and homology modeling shows that GhV-F shares the major structural features associated with other HNV-F proteins, such as a cytoplasmic tail with the YXXL endocytic motif, HR1 and HR2 heptad repeat regions, a hydrophobic fusion peptide immediately following a basic cleavage site, and the conserved cysteines that are thought to link the F 1 and F 2 segments after protease cleavage (Fig. 2) . However, the predicted N terminus of the GhV-F= gene (GenBank no. AFH96010.1) contains ϳ100 amino acids that are not conserved in the N termini of other HNV-F proteins ( Fig. 2A and B) , and bioinformatic analysis indicates the absence of any recognizable signal peptide motif ( Fig. 3A and B; Table 1 ).
Signal peptides (SPs) are usually located within the first 20 to 30 amino acids of the N termini of plasma membrane-associated or secreted proteins, and they are characterized by a preponderance of aliphatic and hydrophobic amino acids, such as leucines and isoleucines (12) . Signal peptidases cleave SPs to generate the mature forms of the associated proteins. Although there is no canonical motif in SPs that predicts cleavage by signal peptidases, SP prediction programs can identify potential SP cleavage sites with high confidence via a combination of contextual cues (refer- ence 13 and references therein). The median length of eukaryotic signal peptides is 22 amino acids (aa) (range, 11 to 55 aa) (12) , and SPs were clearly present in the first ϳ25 amino acids of the F proteins from NiV Malaysia , NiV Bangladesh , HeV, and CedPV but not in GhV-F= (Fig. 3B) . Notably, four independent SP prediction programs failed to identify an SP within the first 70 aa of GhV-F= (Table 1) .
Closer inspection reveals an isoleucine-/leucine-rich region in GhV-F= (105 to 115 aa) that aligns well with the predicted SPs in the other HNV-F proteins (Fig. 3C) . Remarkably, the genomic sequence encoding residues 95 to 115 of GhV-F= is 81% AT rich and includes an out-of-frame ATG start codon motif that is upstream of the isoleucine-/leucine-rich region. Poly(A/T) sequences are known to cause stuttering during PCR amplification (14) , which can result in inadvertent insertions or deletions. Insertion of one nucleotide in silico, which resulted in an in-frame start codon from the nearby ATG, rectified GhV-F= such that the N terminus of GhV-F (ϩ1) aligned much better with the extant HNV-F proteins, both in terms of length and sequence similarity (Fig. 3A and C) . Importantly, a The first 70 amino acids of the indicated HNV-F proteins were analyzed by four signal peptide prediction programs: SignalP, SPEPLip, PreDisi, and Signal-BLAST. Except for GhV-F=, at least three and often all four programs found signal peptide sequences at the N terminus of all HNV-F proteins examined, including the rectified GhV-F
. The predicted signal peptide cleavage sites (between 21 and 28) in all the HNV-F sequences examined are shown. b PreDisi gives a predicted cleavage site of 36 for GhV-F=, but the associated probability score that GhV-F= has a signal peptide is zero. Signal peptide prediction for GhV-F= and other HNV-F proteins. The first 70 amino acids of the indicated HNV-F proteins were bioinformatically analyzed for the presence of signal peptide sequences using four independent signal peptide prediction programs (Table 1) . Results from the SignalP program are graphically presented, as described by Petersen et al. (13) . SignalP is a neural network trained to predict signal peptides and provides three output scores for any query input sequence: the C score (raw cleavage site score [red]), S score (signal peptide score [green]), and Y score (combined cleavage site score [blue]). The C, S, and Y scores (y axis) for each amino acid (x axis) in the HNV-F query sequence are shown. In essence, the S score is high when the SignalP networks predict the sequence to be part of the signal peptide, while the C score is trained to recognize the SP cleavage site and is therefore highest at the first residue after the cleavage site. The Y score is a weighted score that helps identify the most likely cleavage site(s) when there are multiple C-score peaks. See http://www.cbs.dtu.dk/services/Signal P/output.php for details. (C) Alignment of HNV-F amino acid sequences. Insertion of a single nucleotide in GhV-F= creates an isoleucine-/leucine-rich N terminus (dashed box) with a conserved signal peptide (green box). (D) Signal peptide prediction for the rectified GhV-F (ϩ1) proteins GhV-F (ϩA) , GhV-F (ϩC) , GhV-F (ϩG) , and GhV-F (ϩT) . Signal peptide motifs were analyzed using SignalP software, as described for panel B.
the rectified GhV-F (ϩ1) was now predicted to have a bona fide SP ( Fig. 3C ; Table 1 ).
Expression and cleavage of rectified GhV-F (؉1) . Depending on the identity of the inserted nucleotide, there are four possible versions of GhV-F (ϩ1) , each with a different amino acid at position ϩ4 from the new initiator methionine (Fig. 3C) . We generated all four versions of GhV-F (ϩ1) and evaluated their expression and their F 0 ¡ F 1 ϩF 2 cleavage levels, both in whole-cell lysates and in pseudotyped viral particles. Interestingly, while GhV-F= is expressed in whole-cell lysate ( Fig. 4A and B) , the protein is not efficiently cleaved (Fig. 4C) or incorporated into pseudotyped virions ( Fig. 4D and E) . The minimal levels that are cleaved or incorporated suggest that an internal hydrophobic domain might be used inefficiently as a surrogate SP. The diminished incorporation of GhV-F= into virions is consistent with inefficient trafficking through the secretory pathway due to the lack of any obvious SP sequence. GhV-F (ϩT) was poorly expressed in cell lysates ( Fig. 4A  and B ) and on vesicular stomatitis virus (VSV)-⌬G-rLuc pseudotyped particles ( Fig. 4D and E) ; however, cleavage was restored in the GhV-F (ϩA) , GhV-F (ϩC) , and GhV-F (ϩG) proteins ( Fig. 4C  and F) , and all these proteins were more highly incorporated into pseudotyped virions than the fusion-compromised GhV-F= ( Fig.  4D and E) .
GhV-G levels of expression in cell lysates and incorporation into pseudotyped virions appeared to be inversely correlated with the expression levels of the GhV-F construct that was
FIG 4 Expression of different GhV-F
(ϩ1) proteins in association with GhV-G and the resulting effect on pseudotyped virus formation and infectivity. Viral pseudotypes were generated on HEK293T cells transfected with plasmids encoding GhV-G and the GhV-F (ϩ1) variants in a 1:1 ratio. Cells were simultaneously infected with a VSV-⌬G-rLuc virus complemented with VSV-G. At 24 h postinfection (hpi), pseudotype virus-containing media were clarified by low-speed centrifugation and then purified via ultracentrifugation through a 20% sucrose cushion. Purified GhV pseudotype particles (GhVpp) were resuspended in Opti-MEM, aliquoted, and stored at Ϫ80°C. (A and D) Expression of GhV-G and GhV-F= or GhV-F (ϩ1) variants in whole-cell lysates at 24 hpi (A) or in purified GhVpp (D). Primary anti-AU1 and anti-HA antibodies were used to detect AU1-tagged GhV-F and HA-tagged GhV-G, respectively. Fluorescent secondary antibodies were used for quantitative Western blotting, and the blots were imaged on a LI-COR Odyssey scanner. ␤-Tubulin is shown as a loading control. (B and E) The F 0 and F 1 bands from panels A and D were quantified using LI-COR Odyssey software, and expression levels for the GhV-F (ϩ1) variants in whole-cell lysates (B) or GhVpp (E) were normalized to the expression of GhV-F=, which was set at 100%. (C and F) Cleavage efficiency of GhV-F (ϩ1) variants in whole-cell lysates (C) or purified GhVpp (F) based on quantitative Western blot values. Data are presented as percent F cleavage, defined as [F 1 /(F 0 ϩ F 1 )] ϫ 100. GhV-F (ϩT) was barely expressed in cell lysates and purified GhVpp, and thus, reporting cleavage efficiency values would be meaningless (asterisk). Results are representatives of 3 different experiments.
transfected in cis (Fig. 4A and D) . The significance of this is
